Posted on 03/03/2016 4:24:04 AM PST by SatinDoll
Nonsense - the difference is the U.S. government issues patents for new drugs, and doesn't block drug companies from pricing patented drugs so as to recover not just per-unit production costs, but also the costs of developing those drugs and the drugs that never made it to market. If drug companies can no longer do this, there will never be another new drug developed.
Look up the cost of sofosburiv in America And India. It’s so trivially easy to verify that it is embarrassing. Check out the AZ woman charged $80k for 2 doses of $100 scorpion anti venom.
Patented drugs are 50-60% higher here than in France And double the cost of UK and Australia.
Nonsense.
Nonsense - the difference is the U.S. government issues patents for new drugs, and doesn't block drug companies from pricing patented drugs so as to recover not just per-unit production costs, but also the costs of developing those drugs and the drugs that never made it to market. If drug companies can no longer do this, there will never be another new drug developed.
Look up the cost [...]
More cost differentials don't address the point: drug companies need to recover the costs of research, both successful and unsuccessful, from somewhere - and when other nations' price controls and/or poverty prevent them from doing it there, they do it here instead.
'Buy the drugs back from those countries' is a simpleminded nonsolution. Drug companies' first response will be to limit sales to those countries; if they're somehow prevented from doing that (which doesn't seem practically doable and is certainly unconstitutional) then we're right back to no new drugs being developed.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.